Metadatos
Mostrar el registro completo del ítem
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials
Idioma
EN
Article de revue
Este ítem está publicado en
npj Precision Oncology. 2024-10-07, vol. 8, n° 1, p. 227
Resumen en inglés
Selecting patients for phase I cancer trials is crucial to ensure a sufficient life expectancy. Frail patients, better suited for palliative care, should not be exposed to new drugs with minimal benefit. Enrolling patients ...Leer más >